Align Technology: Q3 Earnings Snapshot

Align Technology (ALGN) reported Q3 earnings of $135M, or $1.90 per share, exceeding analysts' estimates of $2.76 per share. Revenue was $1.01B, surpassing expectations of $1B. Shares are down 3% YTD but up 14% over the past year, trading at $152.15.

Original reporting
Published Oct 28, 2026, 8:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 28, 2026, 8:23 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Align Technology: Q3 Earnings Snapshot — source image
Decision brief

The 30-second read

$ALGNBullishHigh
01

Why it matters

The earnings beat reinforces Align's market position and could trigger short‑term buying pressure.

02

Market read

First‑report earnings for a large‑cap tech/healthcare company; likely to move the stock and related sector.

03

What to watch

Potential headwinds from supply chain costs and competition from new clear aligners.

Relevance 8/10Novelty 8/10Timing: post‑market Wednesday

Background

Align Technology (ALGN) is the maker of Invisalign, a leading clear‑aligner system.

Company-level read

Ticker impact

$ALGNBullishHigh confidence
Context

Align Technology reported Q3 earnings beating estimates with $2.80 adjusted EPS and $1.01B revenue.

Expected impact

likely upward pressure as the market prices in the earnings beat

Evidence & confidence

Beat of both EPS and revenue versus Zacks consensus typically drives short-term buying.

Market effects

Dental and orthodontic device sector may see broader optimism from Align's beat.

U.S. tech and healthcare indices could get a modest lift.

Limited to investors tracking large‑cap U.S. earnings.

Counterpoint

Some analysts may view the modest EPS beat as insufficient given high valuation.

Key entities

  • Align Technology Inc.

    Provider of Invisalign clear‑aligner orthodontic solutions.

Related articles

$ALGNMed

Align Technology Inc (ALGN) Q3 2026 Earnings Call Highlights: Record Doctor Submitters

Align Technology (ALGN) reported Q3 2026 earnings with record 91,000 doctor submitters (+3% YoY) and Clear Aligner shipments up 6.6% to 691,000. Non-GAAP operating margin was 24.4%, exceeding outlook. Revenue growth slowed to 1.9% YoY, with Systems & Services revenue down 7.6%. ASP declined 2.3% YoY. Q4 guidance was reduced due to consumer challenges and lower ASP assumptions. The company highlighted innovation in sports mouthguards and margin improvement plans for 2027.

$ALGNMedAI 8/10

ALGN Q3 Earnings & Revenues Beat, '26 Sales View Down, Stock Falls

Align Technology (ALGN) reported Q3 2026 earnings of $2.80 per share, up 7.3% YoY, and revenues of $1.01B, up 1.9% YoY. Clear Aligner shipments increased 6.6% YoY. ALGN shares fell 0.7% post-earnings. The company lowered its 2026 revenue outlook, citing softer expectations for Systems and Services business. Q4 revenue guidance is $1.00-$1.02B, below consensus of $1.05B.